Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

LivaNova (LIVN) Cash & Equivalents (2016 - 2025)

Historic Cash & Equivalents for LivaNova (LIVN) over the last 12 years, with Q3 2025 value amounting to $646.1 million.

  • LivaNova's Cash & Equivalents rose 8653.07% to $646.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $646.1 million, marking a year-over-year increase of 8653.07%. This contributed to the annual value of $428.9 million for FY2024, which is 3773.35% up from last year.
  • Per LivaNova's latest filing, its Cash & Equivalents stood at $646.1 million for Q3 2025, which was up 8653.07% from $593.6 million recorded in Q2 2025.
  • Over the past 5 years, LivaNova's Cash & Equivalents peaked at $738.4 million during Q1 2025, and registered a low of $181.8 million during Q3 2021.
  • Over the past 5 years, LivaNova's median Cash & Equivalents value was $311.4 million (recorded in 2023), while the average stood at $356.9 million.
  • In the last 5 years, LivaNova's Cash & Equivalents crashed by 2017.68% in 2021 and then soared by 13882.87% in 2025.
  • Over the past 5 years, LivaNova's Cash & Equivalents (Quarter) stood at $208.0 million in 2021, then skyrocketed by 44.93% to $301.4 million in 2022, then increased by 3.29% to $311.4 million in 2023, then skyrocketed by 37.73% to $428.9 million in 2024, then soared by 50.65% to $646.1 million in 2025.
  • Its Cash & Equivalents stands at $646.1 million for Q3 2025, versus $593.6 million for Q2 2025 and $738.4 million for Q1 2025.